caa a22 4500 606240918 CHVBK 20210128101310.0 cr unu---uuuuu 210128e20150601xx s 000 0 eng 10.1007/s00508-015-0751-5 doi (NATIONALLICENCE)springer-10.1007/s00508-015-0751-5 Patient's and physician's behavior on the management of benign prostatic hyperplasia among the patients at the risk of clinical progression. A multicenter noninterventional trial in Slovakia by "Prostate and Expectations of Treatment: Epidemiology Research” (PETER) study group [Elektronische Daten] [Peter Weibl, Peter Laurinc, Roman Tomaškin, Tobias Klatte, Shahrokh Shariat F, Miroslav Helbich, Danica Fačkovcova, Peter Bujdák] Summary: Objectives: The aim of the survey was to assess physician's behavior and the global knowledge about patient's preferences and their psychological burden linked to lower urinary tract symptoms (LUTS) in an outpatient setting in Slovakia. Methods: The study included 36 outpatient urological clinics. Overall, 1132 newly diagnosed LUTS patients were screened within 1 month. A total of 454 questionnaires were obtained from 459 LUTS patients with risk of progression (RP). Inclusion criteria were: age > 50 years, IPSS > 8, prostate volume ≥ 30cm3, and PSA ≥ 1.5 to ≤ 10ng/ml. Results: The digital rectal examination, PSA testing, and urinalysis were used in all the centers as first visit examinations. The least frequently performed diagnostic procedure was uroflowmetry (74 %). The physician's preferred therapy for patients with RP was standard combined treatment in (52.6 %); followed by α-blocker alone (45 %) and monotherapy with 5-α-reductase inhibitors (5-ARI) only in 3 % of all asked urologists. Patient's mean age was 63.3 years (SD ±  7.4); baseline PSA value 2.2ng/ml (SD + 3.2); prostate volume was 38.0ml (SD ±  16.7ml); Qmax was 11.5ml/s (SD ±  4.6); and IPSS score 12.5 (SD ±  6.3). The most bothersome symptoms were nocturia (prevalence of ≥ 75 %), weak urinary stream (61 %), and retarded voiding (43 %). Patient's expectations of treatment were rapid improvement of symptoms (36.0 %), stabilization of symptoms (35.5 %), and reduction of potential risk of surgical intervention (25.8 %). Conclusions: Our research reflects the physician's behavior, patient's self-perception of the disease and therapeutic priorities in the current outpatient practice in Slovakia. Springer-Verlag Wien, 2015 Benign prostatic hyperplasia nationallicence Lower urinary tract symptoms nationallicence Patients nationallicence Physician's behavior nationallicence Weibl Peter Department of Urology, Medical University of Vienna, Vienna General Hospital, Währinger Gürtel 18-20, 1090, Vienna, Austria aut Laurinc Peter Department of Urology, University Hospital Žilina, Žilina, Slovakia aut Tomaškin Roman Department of Urology, Medical University of Martin, Martin, Slovakia aut Klatte Tobias Department of Urology, Medical University of Vienna, Vienna General Hospital, Währinger Gürtel 18-20, 1090, Vienna, Austria aut Shariat F Shahrokh Department of Urology, Medical University of Vienna, Vienna General Hospital, Währinger Gürtel 18-20, 1090, Vienna, Austria aut Helbich Miroslav Caldera, Bratislava, Slovakia aut Fačkovcova Danica GlaxoSmithKline- Bratislava, Bratislava, Slovakia aut Bujdák Peter Department of Urology, Slovak Medical University Bratislava, Bratislava, Slovakia aut Wiener klinische Wochenschrift Springer Vienna 127/11-12(2015-06-01), 434-439 0043-5325 127:11-12<434 2015 127 508 https://doi.org/10.1007/s00508-015-0751-5 text/html Onlinezugriff via DOI BK010053 XK010053 XK010000 Metadata rights reserved Springer special CC-BY-NC licence nationallicence 1 research-article jats NATIONALLICENCE NATIONALLICENCE NL-springer NATIONALLICENCE 856 40 https://doi.org/10.1007/s00508-015-0751-5 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Weibl Peter Department of Urology, Medical University of Vienna, Vienna General Hospital, Währinger Gürtel 18-20, 1090, Vienna, Austria aut NATIONALLICENCE 700 1- Laurinc Peter Department of Urology, University Hospital Žilina, Žilina, Slovakia aut NATIONALLICENCE 700 1- Tomaškin Roman Department of Urology, Medical University of Martin, Martin, Slovakia aut NATIONALLICENCE 700 1- Klatte Tobias Department of Urology, Medical University of Vienna, Vienna General Hospital, Währinger Gürtel 18-20, 1090, Vienna, Austria aut NATIONALLICENCE 700 1- Shariat F Shahrokh Department of Urology, Medical University of Vienna, Vienna General Hospital, Währinger Gürtel 18-20, 1090, Vienna, Austria aut NATIONALLICENCE 700 1- Helbich Miroslav Caldera, Bratislava, Slovakia aut NATIONALLICENCE 700 1- Fačkovcova Danica GlaxoSmithKline- Bratislava, Bratislava, Slovakia aut NATIONALLICENCE 700 1- Bujdák Peter Department of Urology, Slovak Medical University Bratislava, Bratislava, Slovakia aut NATIONALLICENCE 773 0- Wiener klinische Wochenschrift Springer Vienna 127/11-12(2015-06-01), 434-439 0043-5325 127:11-12<434 2015 127 508